RP9 anticorps (Middle Region) (FITC)
Aperçu rapide pour RP9 anticorps (Middle Region) (FITC) (ABIN8031746)
Antigène
Voir toutes RP9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Fonction
- Anti-RP9 Antibody FITC Conjugated
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins
-
Purification
- Immunogen affinity purified.
-
Immunogène
- A synthetic peptide corresponding to a sequence in the middle region of human RP9.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Stock
- -20 °C
-
Stockage commentaire
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Date de péremption
- 12 months
-
-
- RP9 (Retinitis Pigmentosa 9 (Autosomal Dominant) (RP9))
-
Autre désignation
- RP9
-
Sujet
-
Background: The protein encoded by this gene can be bound and phosphorylated by the protooncogene PIM1 product, a serine/threonine protein kinase . This protein localizes in nuclear speckles containing the splicing factors, and has a role in pre-mRNA splicing. CBF1-interacting protein (CIR), a corepressor of CBF1, can also bind to this protein and effects alternative splicing. Mutations in this gene result in autosomal dominant retinitis pigmentosa-9. This gene has a pseudogene (GeneID: 441212), which is located in tandem array approximately 166 kb distal to this gene.
Gene Full Name: RP9 pre-mRNA splicing factor
-
ID gène
- 6100
-
UniProt
- Q8TA86
Antigène
-